Overview

The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The study will determine the effects of three doses of Androxal(enclomiphene citrate)on morning testosterone versus AndroGel(approved topical treatment)in men with low testosterone (<350 ng/dL)after 6 weeks of continuous dosing.
Phase:
Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Clomiphene
Enclomiphene
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
Zuclomiphene